[1]
2026. EXPERIENCE IN OPTIMIZING PHARMACOTHERAPY BASED ON CLINICAL OBSERVATIONS OF PATIENTS AFTER MYOCARDIAL INFARCTION WITH CHRONIC HEART FAILURE AND REDUCED AND MID-RANGE LEFT VENTRICULAR EJECTION FRACTION. International journal of medical sciences. 6, 02 (Feb. 2026), 181–184. DOI:https://doi.org/10.55640/.